November 09, 2010 10:26
NPERC, Bayer to conduct joint research on biodegradable injection
Shanghai. November 9. INTERFAX-CHINA - The National Pharmaceutical Engineering Research Center (NPERC), a subsidiary of the Shanghai Institute of Pharmaceutical Industry (SIPI), has signed an agreement with German giant Bayer Schering Pharma AG to conduct joint research on a biodegradable injection drug delivery system, SIPI announced Nov. 8.
The announcement did not disclose the financial terms of the agreement.
NPERC is currently working on 10 different technologies for dosage preparation and drug delivery, including biodegradable microspheres, liposome preparations, a bioadhesive dosage form and an oral suspension sustained release system.
September 23, 2014
Duma could ratify EEU agreement as early as Sept 26
Death toll from Ukrainian conflict tops 3,500 - UN
Estonia lifts defense spending above NATO guidelines
Hot water supplies to resume in Kyiv no later than Oct 15 - authorities
Main indexes of the Russia stock market for September 23
Shoigu: Over 150,000 servicemen involved in Vostok 2014 strategic exercises (Part 2)
Results of Interregional Trading for OFZ & OBR
Capitalization of Russian stock market decreases 0.10% on Tuesday
Aggregated results for trading of shares in Moscow Exchange
Estonia to put electronic surveillance systems on border with Russia
Ten more captured Ukrainian soldiers freed - Poroshenko
RZD's 2015 freight tariffs to be discussed at meeting with Medvedev on Sept 30 - Yakunin
Red Fox planning to open new stores abroad, expand chain in Russia